+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Desmopressin Market by Form, Sales Channel, End-Users - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5888515
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Desmopressin Market grew from USD 1.25 billion in 2023 to USD 1.30 billion in 2024. It is expected to continue growing at a CAGR of 6.68%, reaching USD 1.97 billion by 2030.

Desmopressin, a synthetic analog of the hormone vasopressin, is primarily used to treat conditions such as diabetes insipidus, bedwetting, and hemophilia A. As a market research analyst, it is crucial to delineate the scope and definition of desmopressin's market. The necessity for desmopressin lies in its unique ability to manage symptoms by regulating water balance in the body, making effective treatment available for patients with related conditions. This versatility sees its application across multiple medical scenarios, with a growing market interest in comprehensive formulations for varied delivery methods including tablets, nasal sprays, and injectables, reflecting its broad end-use scope. Market growth is predominantly driven by rising awareness and increasing diagnosis rates of associated disorders, coupled with the expansion of healthcare infrastructure and pharmaceutical advancements. Additionally, aging populations globally present a sustained demand for therapies like desmopressin. The latest opportunities in the market include the potential expansion into developing regions where healthcare access is improving, and the adoption of novel drug delivery technologies which could enhance drug efficacy and patient adherence. However, growth is tempered by several challenges, such as stringent regulatory hurdles, potential side effects of the drug, and competition from alternative treatment options. Innovation can be focused on improving the drug's safety profile and exploring combination therapies that can enhance effectiveness. Additionally, research into more patient-friendly administration routes could provide a competitive edge. The market nature is competitive with a steady influx of generics, urging market players to maintain innovation. Partaking in strategic collaborations and leveraging cutting-edge research in pharmacogenomics could enable businesses to harness unique biomolecular insights for tailored therapies. Overall, balancing regulatory demands with innovative solutions remains key to sustaining competitive advantage and fostering growth within the desmopressin market.

Understanding Market Dynamics in the Desmopressin Market

The Desmopressin Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising occurrence of diabetes insipidus in patients worldwide
    • Government initiatives and programs supporting diabetes awareness & treatment
  • Market Restraints
    • Adverse effects associated with the desmopressin
  • Market Opportunities
    • Ongoing research & development activities for new formulations
    • Increasing in regulatory approvals for desmopressin
  • Market Challenges
    • Availability of alternative medicines

Exploring Porter’s Five Forces for the Desmopressin Market

Porter’s Five Forces framework further strengthens the insights of the Desmopressin Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Desmopressin Market

External macro-environmental factors deeply influence the performance of the Desmopressin Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Desmopressin Market

The Desmopressin Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Desmopressin Market

The Desmopressin Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Desmopressin Market

The Desmopressin Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Desmopressin Market, highlighting leading vendors and their innovative profiles. These include AA Pharma Inc., Amring Pharmaceuticals Inc., Antares Pharma, Inc. by Halozyme, Inc., Apotex Inc., Avadel Pharmaceuticals PLC, Bachem AG, BluePoint Laboratories, CSC Pharmaceuticals International, Dr. Reddy's Laboratories Ltd., Enomark, Ferring Pharmaceuticals, Glenmark Pharmaceuticals Limited, Horizon NJ Health by Horizon Blue Cross Blue Shield of New Jersey, KVR Pharmaceuticals, Manus Aktteva Biopharma LLP, Midas Pharma GmbH, NorthStar Rx LLC, Pfizer Inc., Ralington Pharma LLP, Saintroy Lifescience, Sanofi S.A., Sava Healthcare Limited, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., and VIVAN Life Sciences Pvt. Limited.

Market Segmentation & Coverage

This research report categorizes the Desmopressin Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Form
    • Injectable Solution
    • Nasal Spray
    • Tablet
  • Sales Channel
    • Offline
    • Online
  • End-Users
    • Homecare
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising occurrence of diabetes insipidus in patients worldwide
5.1.1.2. Government initiatives and programs supporting diabetes awareness & treatment
5.1.2. Restraints
5.1.2.1. Adverse effects associated with the desmopressin
5.1.3. Opportunities
5.1.3.1. Ongoing research & development activities for new formulations
5.1.3.2. Increasing in regulatory approvals for desmopressin
5.1.4. Challenges
5.1.4.1. Availability of alternative medicines
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Desmopressin Market, by Form
6.1. Introduction
6.2. Injectable Solution
6.3. Nasal Spray
6.4. Tablet
7. Desmopressin Market, by Sales Channel
7.1. Introduction
7.2. Offline
7.3. Online
8. Desmopressin Market, by End-Users
8.1. Introduction
8.2. Homecare
8.3. Hospitals
8.4. Specialty Clinics
9. Americas Desmopressin Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Desmopressin Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Desmopressin Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. DESMOPRESSIN MARKET RESEARCH PROCESS
FIGURE 2. DESMOPRESSIN MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DESMOPRESSIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DESMOPRESSIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DESMOPRESSIN MARKET SIZE, BY FORM, 2023 VS 2030 (%)
FIGURE 7. GLOBAL DESMOPRESSIN MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2023 VS 2030 (%)
FIGURE 9. GLOBAL DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL DESMOPRESSIN MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 11. GLOBAL DESMOPRESSIN MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES DESMOPRESSIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES DESMOPRESSIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. DESMOPRESSIN MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. DESMOPRESSIN MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DESMOPRESSIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DESMOPRESSIN MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DESMOPRESSIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. DESMOPRESSIN MARKET DYNAMICS
TABLE 7. GLOBAL DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DESMOPRESSIN MARKET SIZE, BY INJECTABLE SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DESMOPRESSIN MARKET SIZE, BY NASAL SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DESMOPRESSIN MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DESMOPRESSIN MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DESMOPRESSIN MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DESMOPRESSIN MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DESMOPRESSIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DESMOPRESSIN MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 28. CANADA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 29. CANADA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. CANADA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 31. MEXICO DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 32. MEXICO DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. MEXICO DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES DESMOPRESSIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 45. CHINA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 46. CHINA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. CHINA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 48. INDIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 49. INDIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. INDIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 54. JAPAN DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 55. JAPAN DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. JAPAN DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 72. THAILAND DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 73. THAILAND DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. THAILAND DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA DESMOPRESSIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. DENMARK DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 83. DENMARK DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. DENMARK DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 85. EGYPT DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 86. EGYPT DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. EGYPT DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 88. FINLAND DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 89. FINLAND DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. FINLAND DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 91. FRANCE DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 92. FRANCE DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. FRANCE DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 94. GERMANY DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 95. GERMANY DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. GERMANY DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 100. ITALY DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 101. ITALY DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. ITALY DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 109. NORWAY DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 110. NORWAY DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. NORWAY DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 112. POLAND DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 113. POLAND DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. POLAND DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 115. QATAR DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 116. QATAR DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. QATAR DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 127. SPAIN DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 128. SPAIN DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. SPAIN DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 136. TURKEY DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 137. TURKEY DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. TURKEY DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM DESMOPRESSIN MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM DESMOPRESSIN MARKET SIZE, BY SALES CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM DESMOPRESSIN MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 145. DESMOPRESSIN MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. DESMOPRESSIN MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Desmopressin Market, which are profiled in this report, include:
  • AA Pharma Inc.
  • Amring Pharmaceuticals Inc.
  • Antares Pharma, Inc. by Halozyme, Inc.
  • Apotex Inc.
  • Avadel Pharmaceuticals PLC
  • Bachem AG
  • BluePoint Laboratories
  • CSC Pharmaceuticals International
  • Dr. Reddy's Laboratories Ltd.
  • Enomark
  • Ferring Pharmaceuticals
  • Glenmark Pharmaceuticals Limited
  • Horizon NJ Health by Horizon Blue Cross Blue Shield of New Jersey
  • KVR Pharmaceuticals
  • Manus Aktteva Biopharma LLP
  • Midas Pharma GmbH
  • NorthStar Rx LLC
  • Pfizer Inc.
  • Ralington Pharma LLP
  • Saintroy Lifescience
  • Sanofi S.A.
  • Sava Healthcare Limited
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • VIVAN Life Sciences Pvt. Limited

Methodology

Loading
LOADING...

Table Information